Kazuhiro Terai

Title: Kazuhiro Terai: Innovator in Pharmaceutical Compounds

Introduction

Kazuhiro Terai is a notable inventor based in Chuo-ku, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in developing compounds that target specific health conditions. With a total of 3 patents to his name, Terai's work focuses on innovative solutions for treating hyperphosphatemia.

Latest Patents

One of Terai's latest patents involves a tetrahydrobenzothiophene compound. This compound is designed to provide an intestinal phosphate transporter (NPT-IIb) inhibitory action, making it useful as an active ingredient in agents aimed at treating and preventing hyperphosphatemia. The compound is characterized by its unique formula (I), which demonstrates its effectiveness in this area. Another significant patent is for an aminoalkyl-substituted N-thienylbenzamide derivative. This compound also exhibits NPT-IIb inhibitory action and serves as an active ingredient for agents targeting hyperphosphatemia. Through extensive research, Terai and his team have successfully developed these compounds to address critical health issues.

Career Highlights

Kazuhiro Terai is currently associated with Astellas Pharma GmbH, where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing treatments that improve patient outcomes.

Collaborations

Terai has collaborated with notable colleagues, including Masanori Miura and Daisuke Kaga. Their combined expertise has contributed to the successful development of the compounds for which Terai holds patents.

Conclusion

Kazuhiro Terai's contributions to pharmaceutical innovations highlight his commitment to improving health outcomes through targeted treatments. His work in developing compounds for hyperphosphatemia showcases the importance of research and collaboration in the field of medicine.